Source: British Journal of Pharmacology. Unidade: ICB
Subjects: FARMACOLOGIA, ANSIEDADE, OCITOCINA, COMPORTAMENTO SOCIAL, VASOPRESSINAS, TRANSTORNOS DA ANSIEDADE, PEPTÍDEOS
ABNT
RAE, Mariana Beu et al. Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects. British Journal of Pharmacology, v. 179, n. 8, p. 1544-1564, 2022Tradução . . Disponível em: https://doi.org/10.1111/bph.15481. Acesso em: 17 nov. 2024.APA
Rae, M. B., Duarte, M. L., Gomes, I., Camarini, R., & Devi, L. A. (2022). Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects. British Journal of Pharmacology, 179( 8), 1544-1564. doi:10.1111/bph.15481NLM
Rae MB, Duarte ML, Gomes I, Camarini R, Devi LA. Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects [Internet]. British Journal of Pharmacology. 2022 ; 179( 8): 1544-1564.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1111/bph.15481Vancouver
Rae MB, Duarte ML, Gomes I, Camarini R, Devi LA. Oxytocin and vasopressin: Signalling, behavioural modulation and potential therapeutic effects [Internet]. British Journal of Pharmacology. 2022 ; 179( 8): 1544-1564.[citado 2024 nov. 17 ] Available from: https://doi.org/10.1111/bph.15481